BioArctic receives new drug substance patent in the US for ABBV-0805 against Parkinson’s disease
STOCKHOLM, May 6, 2022 /PRNewswire/ — BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US Patent and Trademark Office (USPTO) has granted a new drug substance patent for the antibody ABBV-0805, invented by BioArctic as a potential treatment of Parkinson’s disease….
Comments Off on
BioArctic receives new drug substance patent in the US for ABBV-0805 against Parkinson’s disease